Day: November 25, 2022

Ren, Lei published the artcileEffect of celecoxib combined with parecoxib sodium for preemptive analgesia after lumbar fusion surgery, Safety of Sodium ((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide, the publication is Hebei Yixue (2017), 23(8), 1352-1356, database is CAplus.

Objective: To observe the effect of celecoxib combined with parecoxib sodium for preemptive analgesia in the treatment of early pain after lumbar fusion surgery. Methods: Between Nov. 2015 and June 2016, 105 patients who were planned to undergo posterior lumbar fusion were excluded from the history of peptic ulcer and coronary heart disease (35 cases of lumbar spinal stenosis, 50 cases of lumbar disk herniation, 20 cases of degenerative lumbar spondylolisthesis) were randomly divided into 3 groups with 35 persons in each group. Group A was given postoperative celecoxib + patient controlled analgesia (patient controlled analgesia, PCA) group, group B was postoperative parecoxib sodium + PCA pump group, and group C was celecoxib combined with parecoxib sodium + PCA pump for perioperative preemptive analgesia. There were no significant differences in disease distribution, gender, age, or weight among the three groups (P > 0.05). All patients underwent general anesthesia for tracheal intubation, posterior laminar decompression, intervertebral bone graft fusion, and pedicle screw internal fixation. The three groups of patients were given the corresponding medication regimen according to the grouping situation, and was administered with fentanyl for PCA after the operation. The observation indicators were the visual analog score, the dosage of analgesic pump drugs, and the incidence of adverse reactions such as nausea, vomiting, and constipation. Results: The postoperative analgesic effect of group C is better than that of group A and group B. The dosage of fentanyl in group C was less than that in group A and group B. The incidence of adverse reactions in group C was significantly lower than that in group A. There was no significant difference in the incidence of adverse reactions in group B and C. Conclusion: The preemptive analgesia of celecoxib combined with parecoxib sodium for early postoperative pain after lumbar posterior fusion surgery is better, and the analgesic effect is better than that of celecoxib or parecoxib sodium alone. It can reduce the amount of opioids, while reducing the incidence of adverse reactions.

Hebei Yixue published new progress about 198470-85-8. 198470-85-8 belongs to isoxazole, auxiliary class Immunology/Inflammation,COX, name is Sodium ((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide, and the molecular formula is C19H17N2NaO4S, Safety of Sodium ((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem

Sibi, Mukund P. published the artcileEnantioselective intermolecular free radical conjugate additions. Application of a pyrazole template, SDS of cas: 182122-10-7, the publication is Tetrahedron Letters (1997), 38(34), 5955-5958, database is CAplus.

An achiral pyrazole template has been evaluated in enantioselective conjugate radical additions The enantioselectivity using the pyrazole template is inferior to those obtained from an oxazolidinone template. The two templates give products of opposite configuration using the same chiral Lewis acid.

Tetrahedron Letters published new progress about 182122-10-7. 182122-10-7 belongs to isoxazole, auxiliary class BOX or PyBox,BOX or PyBox, name is (3aS,3a’S,8aR,8a’R)-2,2′-(Cyclobutane-1,1-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole), and the molecular formula is C8H17Br, SDS of cas: 182122-10-7.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem

Polenz, Ingmar published the artcileKinetic studies on the imine base/isocyanate-induced radical polymerization of vinyl monomers, COA of Formula: C9H7NO2, the publication is Journal of Polymer Science, Part A: Polymer Chemistry (2012), 50(16), 3324-3331, S3324/1-S3324/24, database is CAplus.

Specific imine bases (IB) in conjunction with various isocyanates (IC) mediate the radical polymerization of radically polymerizable monomers such as Me methacrylate (MMA). Advantageously, the 2-(methylmercapto)-2-thiazoline MMT/IC combination as initiator works even at room temperature for polymerization of MMA. The coefficients a, b, and c of the basic rate law of monomer consumption d[M]/dt = k_p·[IC]^a·[IB]^b·[M]^c were determined The order a has been determined to 0.5 showing the root law of radical polymerization with respect to the IC component as initiator. Moreover, b and c amount 1. The initiator combination MMT/ IC was applied to determine the influence of the mol. structure of the IC on the rate of monomer conversion. For aromatic isocyantes, the brutto rate constant of monomer consumption correlates with the Hammet constant of aromatic substituents. The activation energies of the brutto polymerization rate constant of several initiator mixtures were determined whereby the value of E_A,Br was found to be between typical values of radical polymerization initiated by photochem. reactions (∼20 kJ/mol) and commonly used thermal decomposing initiators (∼80 kJ/mol). Presumptions on the initiating and terminating step of the IB/IC mediated polymerization were done by means of electrospray ionization mass spectrometry, NMR spectroscopy, and the elemental composition of the head and end group of the resulting polymers. © 2012 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem, 2012.

Journal of Polymer Science, Part A: Polymer Chemistry published new progress about 1076-59-1. 1076-59-1 belongs to isoxazole, auxiliary class Oxazoline,Benzene,Ester, name is 3-Phenylisoxazol-5(2H)-one, and the molecular formula is C9H7NO2, COA of Formula: C9H7NO2.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem

Rajamanickam, Suresh published the artcileIntermolecular CDC amination of remote and proximal unactivated C_sp³-H bonds through intrinsic substrate reactivity – expanding towards a traceless directing group, Application In Synthesis of 2251-79-8, the publication is Chemical Science (2021), 12(46), 15318-15328, database is CAplus and MEDLINE.

An intermol. radical based distal selectivity in appended alkyl chains, e.g., I has been developed. The selectivity is maximum when the distal carbon is γ to the appended group and decreases by moving from γ → δ → ε positions. In -COO- linked alkyl chains, the same distal γ-selectivity is observed irresp. of its origin, either from the alkyl carboxy acid or alkyl alc. The appended groups include esters, N-H protected amines, phthaloyl, sulfone, sulfinimide, nitrile, phosphite, phosphate and borate esters. In borate esters, boron serves as a traceless directing group, which is hitherto unprecedented for any remote C_sp³-H functionalization. The selectivity order follows the trend: 3° benzylic > 2° benzylic > 3° tertiary > α to keto > distal methylene (γ > δ > ε). Computations predicted the radical stability (thermodn. factors) and the kinetic barriers as the factors responsible for such trends. Remarkably, this strategy eludes any designer catalysts, and the selectivity is due to the intrinsic substrate reactivity.

Chemical Science published new progress about 2251-79-8. 2251-79-8 belongs to isoxazole, auxiliary class Trifluoromethyl,Fluoride,Benzene, name is 5-(4-(Trifluoromethyl)phenyl)-1H-tetrazole, and the molecular formula is C8H5F3N4, Application In Synthesis of 2251-79-8.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem

Vergani, Barbara published the artcileNovel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation, Synthetic Route of 2251-79-8, the publication is Journal of Medicinal Chemistry (2019), 62(23), 10711-10739, database is CAplus and MEDLINE.

Histone deacetylase 6 (HDAC6) is a peculiar HDAC isoform whose expression and functional alterations were correlated with a variety of pathologies such as autoimmune disorders, neurodegenerative diseases, and cancer. It is primarily a cytoplasmic protein, and its deacetylase activity is focused mainly on non-histone substrates such as tubulin, heat shock protein (HSP)90, Foxp3 and cortactin, to name a few. Selective inhibition of HDAC6 does not show cytotoxic effects in healthy cells, normally associated with the inhibition of Class I HDAC isoforms. Here the authors describe the design and synthesis of a new class of potent and selective HDAC6 inhibitors that bear a pentaheterocyclic central core. These compounds show a remarkably low toxicity both in vitro and in vivo and are able to increase the function of regulatory T cells (Tregs) at well tolerated concentrations, suggesting a potential clin. use for the treatment of degenerative, auto-immune diseases and organ transplantation.

Journal of Medicinal Chemistry published new progress about 2251-79-8. 2251-79-8 belongs to isoxazole, auxiliary class Trifluoromethyl,Fluoride,Benzene, name is 5-(4-(Trifluoromethyl)phenyl)-1H-tetrazole, and the molecular formula is C8H5F3O2S, Synthetic Route of 2251-79-8.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem

Dal Monte, D. published the artcile2,1,3-Benzothia-, selena-, and oxadiazoles. III. Amine derivatives, Category: isoxazole, the publication is Bollettino Scientifico della Facolta di Chimica Industriale di Bologna (1964), 22(2), 33-40, database is CAplus.

cf. CA 61, 10573c. Uv spectra of I and II (X = O, S, and Se) were presented and discussed. The following pK_a, values in H₂O at 25° were calculated: I (X = S), 2.02; I (X = Se), 2.18; I (X = O), 0.78; II (X = S), 2.01; II (X = 0),0.77; the OH analogs have pK_a, 7.86, 8.16, 6.83, 8.16, and 7.28, resp. I (X = O), m. 110-11°, and II (X = O), m. 127-9°, were prepared by heating 3.1 g. 4- or 5-chloro compound with 0.8 g. CuSO₄ in 80 cc. 20% NH₃ 8 hrs. in a sealed tube at 140-50°.

Bollettino Scientifico della Facolta di Chimica Industriale di Bologna published new progress about 874-36-2. 874-36-2 belongs to isoxazole, auxiliary class Other Aromatic Heterocyclic,Amine, name is Benzo[c][1,2,5]oxadiazol-5-amine, and the molecular formula is C6H5N3O, Category: isoxazole.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem

Ali, Meissam published the artcileScreening of Synthetic Isoxazolone Derivative Role in Alzheimer’s Disease: Computational and Pharmacological Approach, Recommanded Product: 3-Phenylisoxazol-5(2H)-one, the publication is Neurochemical Research (2021), 46(4), 905-920, database is CAplus and MEDLINE.

Abstract: Alzheimer’s disease (AD) is age-dependent neurol. disorder with progressive loss of cognition and memory. This multifactorial disease is characterized by intracellular neurofibrillary tangles, beta amyloid plaques, neuroinflammation, and increased oxidative stress. The increased cellular manifestations of these markers play a critical role in neurodegeneration and pathogenesis of AD. Therefore, reducing neurodegeneration by decreasing one or more of these markers may provide a potential therapeutic roadmap for the treatment of AD. AD causes a devastating loss of cognition with no conclusive and effective treatment. Many synthetic compound containing isoxazolone nucleus have been reported as neuroprotective agents. The aim of this study was to explore the anti-Alzheimer’s potential of a newly synthesized 3,4,5-trimethoxy isoxazolone derivative (TMI) that attenuated the beta amyloid (Aβ1-42) and tau protein levels in streptozotocin (STZ) induced Alzheimer’s disease mouse model. Mol. anal. revealed increased beta amyloid (Aβ1-42) protein levels, increased tau protein levels, increased cellular oxidative stress and reduced antioxidant enzymes in STZ exposed mice brains. Furthermore, ELISA and PCR were used to validate the expression of Aβ1-42. Pre-treatment with TMI significantly improved the memory and cognitive behavior along with ameliorated levels of Aβ1-42 proteins. TMI treated mice further showed marked increase in GSH, CAT, SOD levels while decreased levels of acetylcholinesterase inhibitors (AChEI’s) and MDA intermediate. The multidimensional nature of isoxazolone derivatives and its versatile affinity towards various targets highpoint its multistep targeting nature. These results indicated the neuroprotective potential of TMI which may be considered for the treatment of neurodegenerative disease specifically in AD.

Neurochemical Research published new progress about 1076-59-1. 1076-59-1 belongs to isoxazole, auxiliary class Oxazoline,Benzene,Ester, name is 3-Phenylisoxazol-5(2H)-one, and the molecular formula is C9H7NO2, Recommanded Product: 3-Phenylisoxazol-5(2H)-one.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem

Rajamanickam, Suresh published the artcileBu₄NI-Catalyzed, Radical-Induced Regioselective N-Alkylations and Arylations of Tetrazoles Using Organic Peroxides/Peresters, Formula: C8H5F3N4, the publication is Journal of Organic Chemistry (2020), 85(4), 2118-2141, database is CAplus and MEDLINE.

Bu₄NI-catalyzed regioselective N²-methylation, N²-alkylation, and N²-arylation of tetrazoles have been achieved using tert-Bu hydroperoxide (TBHP) as the Me source, alkyl diacyl peroxides as the primary alkyl source, alkyl peresters as the secondary and tertiary alkyl sources, and aryl diacyl peroxides as the arylating source. These reactions proceed without pre-functionalization of tetrazole and in the absence of any metal catalysts. Here, peroxides serve the dual role of oxidants as well as alkylating or arylating agents. Based on DFT calculations, it was found that spin d., transition-state barriers (kinetic control), and thermodn. stability of the products (thermodn. control) play essential roles in the observed regioselectivity during N-alkylation. This radical-mediated process is amenable to a broad range of substrates and provides products in moderate to good yields.

Journal of Organic Chemistry published new progress about 2251-79-8. 2251-79-8 belongs to isoxazole, auxiliary class Trifluoromethyl,Fluoride,Benzene, name is 5-(4-(Trifluoromethyl)phenyl)-1H-tetrazole, and the molecular formula is C8H5F3N4, Formula: C8H5F3N4.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem

Elinson, Michail N. published the artcileElectrochemically Induced Facile and Efficient Multicomponent Approach to Medicinally Relevant 4-[4-oxo-4H-pyran-2-yl](aryl)-methylisoxazol-5(2H)-one Scaffold, SDS of cas: 1076-59-1, the publication is ChemistrySelect (2020), 5(20), 5981-5986, database is CAplus.

The new electrochem. induced multicomponent assembling has been accomplished: the electrocatalytic transformation of aldehydes R¹CHO (R¹ = 4-chlorophenyl, pyridin-3-yl, naphthalen-1-yl, etc.), 3-aryl-substituted isoxazol-5(4H)-ones I (R² = H, Br, Cl, F) and kojic acid has been carried out in n-propanol in an undivided cell in the presence of sodium bromide. This transformation proceeds with the selective formation of the earlier unknown substituted 4-([3-hydroxy-6-(hydroxymethyl)-4-oxo-4H-pyran-2-yl]-(aryl)methyl)-isoxazol-5(2H)-ones II in 57-93% yields with 190-310% current efficiency. This new electrocatalytic process provides a facile and efficient way to the separated C-aryl-substituted spacer 3-arylisoxazol-5(4H)-ones I and kojic acid pharmacol. active heterocyclic fragments, which are promising compounds II [R¹ = Ph, R² = Br; R¹ = 3-methylpheny, R² = Br; R¹ = 4-(methoxycarbonyl)phenyl, R² = Br; R¹ = 4-nitrophenyl, R² = F] for different biomedical applications, and, in particular, for regulation of inflammatory as was shown by docking studies in this research.

ChemistrySelect published new progress about 1076-59-1. 1076-59-1 belongs to isoxazole, auxiliary class Oxazoline,Benzene,Ester, name is 3-Phenylisoxazol-5(2H)-one, and the molecular formula is C9H7NO2, SDS of cas: 1076-59-1.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem

Gutmann, Bernhard published the artcileSynthesis of 5-Substituted 1H-Tetrazoles from Nitriles and Hydrazoic Acid by Using a Safe and Scalable High-Temperature Microreactor Approach, Name: 5-(4-(Trifluoromethyl)phenyl)-1H-tetrazole, the publication is Angewandte Chemie, International Edition (2010), 49(39), 7101-7105, S7101/1-S7101/12, database is CAplus and MEDLINE.

A general and scalable method for the continuous flow synthesis of 5-substituted 1H-tetrazole derivatives via addition of HN₃ to organic nitriles is described. Key to this process is the in situ generation of HN₃ from NaN₃ and acetic acid in a microreactor coupled to an intensified high-temperature/high-pressure flow addition step to the nitrile. Under optimized conditions, tetrazole compounds are formed with quant. conversion in residence times of a few minutes, providing excellent purities and yields of isolated product.

Angewandte Chemie, International Edition published new progress about 2251-79-8. 2251-79-8 belongs to isoxazole, auxiliary class Trifluoromethyl,Fluoride,Benzene, name is 5-(4-(Trifluoromethyl)phenyl)-1H-tetrazole, and the molecular formula is C8H5F3N4, Name: 5-(4-(Trifluoromethyl)phenyl)-1H-tetrazole.

Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem